HUP9801941A2 - Kaposi-szarkómához és retroperitoneális fibromatózishoz társuló gamma herpeszvírusok DNS polimeráza - Google Patents

Kaposi-szarkómához és retroperitoneális fibromatózishoz társuló gamma herpeszvírusok DNS polimeráza

Info

Publication number
HUP9801941A2
HUP9801941A2 HU9801941A HUP9801941A HUP9801941A2 HU P9801941 A2 HUP9801941 A2 HU P9801941A2 HU 9801941 A HU9801941 A HU 9801941A HU P9801941 A HUP9801941 A HU P9801941A HU P9801941 A2 HUP9801941 A2 HU P9801941A2
Authority
HU
Hungary
Prior art keywords
dna polymerase
kaposi
sarcoma
herpes viruses
viruses associated
Prior art date
Application number
HU9801941A
Other languages
English (en)
Inventor
Mamix L. Bosch
Timothy M. Rose
Kurt Strand
George J. Todaro
Original Assignee
University Of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Washington filed Critical University Of Washington
Publication of HUP9801941A2 publication Critical patent/HUP9801941A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16411—Rhadinovirus, e.g. human herpesvirus 8
    • C12N2710/16422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A találmány tárgya a virőlógia területére esik. A találmányközelebbről a herpeszcsaládba tartőzó vírűsőkra vőnatkőzik. Mégközelebbről, a találmány tárgyát egy DNS pőlimeráz azőnősítása ésjellemzése és alkalmazása képezi egy, a főemlősökben - beleértve azembereket is - előfőrdűló fibrőprőliferációs és neőplaziásállapőtőkkal társűlt vírűsőkból álló alcsaládőn belül. A találmányszerinti DNS pőlimeráz alkalmas mőlekűláris biőlógiai reagenskénttörténő felhasználásra, és alkalmazható diagnősztikűmként is,vírűsfertőzöttség megálapítására. ŕ
HU9801941A 1995-07-14 1996-07-12 Kaposi-szarkómához és retroperitoneális fibromatózishoz társuló gamma herpeszvírusok DNS polimeráza HUP9801941A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US114895P 1995-07-14 1995-07-14

Publications (1)

Publication Number Publication Date
HUP9801941A2 true HUP9801941A2 (hu) 1998-11-30

Family

ID=21694624

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801941A HUP9801941A2 (hu) 1995-07-14 1996-07-12 Kaposi-szarkómához és retroperitoneális fibromatózishoz társuló gamma herpeszvírusok DNS polimeráza

Country Status (12)

Country Link
US (1) US5925733A (hu)
EP (1) EP0842277A1 (hu)
JP (1) JP2002515725A (hu)
KR (1) KR19990028971A (hu)
CN (1) CN1196089A (hu)
AU (1) AU6676496A (hu)
BR (1) BR9609713A (hu)
CA (1) CA2226872A1 (hu)
CZ (1) CZ6098A3 (hu)
HU (1) HUP9801941A2 (hu)
NO (1) NO980148L (hu)
WO (1) WO1997004105A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001296864A1 (en) 2000-08-31 2002-03-13 Mayo Foundation For Medical Education And Research Detection of varicella-zoster virus
AU2003268107A1 (en) * 2002-08-14 2004-03-03 The Board Of Regents Of The University Of Texas System Clinical assays for the detection and typing of human herpesviruses
GB0313132D0 (en) * 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
US20120082677A1 (en) * 2010-10-01 2012-04-05 Sherif Salah Abdul Aziz Compositions for the treatment of hcv and hbv
WO2014079464A1 (en) * 2012-11-21 2014-05-30 Sherif Salah Abdul Aziz A novel enzymes compositions for treatment of human immunodeficiency virus (hiv) infection
WO2014110127A1 (en) * 2013-01-08 2014-07-17 Enzo Biochem, Inc. Diagnosis and treatment of viral diseases
US9617607B2 (en) 2013-01-08 2017-04-11 Enzo Biochem, Inc. Diagnosis and treatment of viral diseases
CN105392903B (zh) * 2014-05-02 2021-05-04 生物辐射实验室股份有限公司 预扩增试验

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
CA1335718C (en) * 1988-04-14 1995-05-30 Mary L. Haffey Expression of a functional form of a herpes virus dna polymerase in yeast
US5120639A (en) * 1989-04-03 1992-06-09 E. R. Squibb & Sons, Inc. Selective inhibition of dna polymerase
US5223391A (en) * 1990-02-21 1993-06-29 President And Fellows Of Harvard College Inhibitors of herpes simplex virus replication
JP3167138B2 (ja) * 1991-02-25 2001-05-21 株式会社ヤトロン 単純ヘルペスウイルスの型特異的検出方法

Also Published As

Publication number Publication date
MX9800392A (es) 1998-09-30
CZ6098A3 (cs) 1998-08-12
WO1997004105A1 (en) 1997-02-06
AU6676496A (en) 1997-02-18
KR19990028971A (ko) 1999-04-15
CN1196089A (zh) 1998-10-14
NO980148L (no) 1998-03-13
CA2226872A1 (en) 1997-02-06
EP0842277A1 (en) 1998-05-20
NO980148D0 (no) 1998-01-13
BR9609713A (pt) 1999-12-21
US5925733A (en) 1999-07-20
JP2002515725A (ja) 2002-05-28

Similar Documents

Publication Publication Date Title
ATE60800T1 (de) Klonierte dns-sequenzen, hybridisierbar mit genom-rns vom ''lymphadenopathy-associated virus (lav)''.
FI875082A (fi) Dna-sekvensser deriverade fraon genom av papillomavirus, deras anvaendning foer in vitro diagnostiska aendamaol; samt framstaellning av antigeniska kompositioner.
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
CA2296144A1 (en) Oligonucleotide primers for efficient detection of hepatitis c virus (hcv) and methods of use thereof
DE69804464D1 (de) Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
ATE315667T1 (de) Amplifizierung und detektion von hiv-1 und/oder hiv-2
BR9807873A (pt) Vacinas de flavivìrus quiméricos
HUP9801941A2 (hu) Kaposi-szarkómához és retroperitoneális fibromatózishoz társuló gamma herpeszvírusok DNS polimeráza
DE69737628D1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
AU8482691A (en) Nucleotide sequences useful as type-specific probes, pcr primers and lcr probes for the amplification and detection of human papilloma virus, and related kits and methods
DE69933121D1 (de) Methode, reagent und testsatz zur typisierung des genoms von papillomavirus
DE69231143D1 (de) Spezifische Nukleotidsequenz enthaltender Masernvirusvakzinstamm und Verfahren zu seiner absoluten Identifizierung
DE69730760D1 (de) Identifizierung, Reinigung und Nachweis von WSBV (Baculovirus das mit dem Syndrom der weissen Flecken assoziert ist)
ES2048652B1 (es) Procedimientos de amplificacion de genoma para la deteccion e identificacion de secuencias genomicas relacionadas.
BR9605926A (pt) Utilização de um material viral e retroviral de um fragmento de nucleotideo de um indicador especifico de uma sonda de um agente patógeno e/ou infeccioso de uma associação de fragmentos nucleotideos processo para a obtenção de um primeiro agente patogeno e/ou infeccioso indicador especifico para a ampliação por plimerização de rna ou dna de um material viral e sonda suscetivel de hibridizar especificamente com rna ou dna de um material viral
WO1997008531A3 (en) Detection of hepatitis gb virus genotypes
Fenner et al. Polymerase chain reaction: detection of varicella-zoster virus
Cheng Comparing RNA PCR tests
ITMI951683A0 (it) Oligonucleotidi hpv-specifici (sp) loro combinazioni e metodo per la determinazione dei papilloma virus uman (hpv) mediante reazione della polimerasi (pcr) e successiva identificazione del dna amplificato del tipo virale mediante analisi di restrizione
WO1999007885A3 (de) Verwendung von primern für universelle fingerprint-analysen
RU93013954A (ru) Способ обнаружения вируса иммунодефицита
AU1393888A (en) A method of detection of carcinogenic human papillomavirus